Lung cancer survivors at high risk for recurrence, new lung cancer
the ONA take:
According to a new study presented at the American Thoracic Society (ATS) 2015 International Conference in Denver, Colorado, researchers have found that many lung cancer survivors are at high risk for developing recurrence of their disease or developing another another lung cancer.
For the study, researchers identified 192 lung cancer survivors who underwent surveillance for an average duration of about 8.5 years. Results showed that 38% of patients had developed recurrence or a new lung cancer during this period.
Researchers also found that for every additional pack of cigarettes smoked per year, patients had a 1% increased risk for developing lung cancer again. Other significant risk factors included presence of a nodule on a CT chest scan, premalignant lesions on three autofluorescence bronchoscopy exams anywhere in the central airway, and having recurrence of another non-lung cancer.
"We looked closely at risk factors that may help in predicting cancer recurrence in lung cancer survivors," said study lead author Samjot Dhillon, MD. "What we learned is that patients with a history of lung cancer should have close long-term surveillance so their doctor can detect early on if the cancer is recurring or if there is another cancer developing."
Many lung cancer survivors are at high risk for developing recurrence of their disease or developing another another lung cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|